Basic Studies Department, School of Dentistry, Universidad de Antioquia UdeA, Medellín 050010, Colombia.
Emergency Department, Universidad Pontificia Bolivariana, Medellín 050010, Colombia.
Medicina (Kaunas). 2023 Sep 26;59(10):1719. doi: 10.3390/medicina59101719.
: is a prevalent bacterium capable of inducing various infections, including skin and soft tissue infections, bloodstream infections, pneumonia, and surgical site infections. The emergence of antimicrobial resistance in , particularly methicillin-resistant , has raised substantial concerns within global healthcare settings. Prior to antibiotic prescription, the ideal approach is antimicrobial susceptibility testing (AST); however, this is frequently perceived as excessively complex and time-intensive. Lab-on-a-chip (LOC) technology holds promise in addressing these challenges and advancing fundamental microbiological research while also aiding in the development of therapeutic strategies. This systematic review aims to evaluate the potential utility of LOC for AST of . : This study adhered to the PRISMA guidelines. Various databases, including SCOPUS, PubMed/MEDLINE, SCIELO, and LILACS, in addition to gray literature sources, were employed in the review process. : Sixteen studies were included in this systematic review. All these studies detailed the effectiveness, rapidity, and predictability of LOC systems for assessing susceptibility to various antibiotics. When comparing the LOC approach to traditional manual methods, it was evident that LOC requires a minimal quantity of reagents. Furthermore, most studies reported that the entire LOC procedure took 10 min to 7 h, with results being equally accurate as those obtained through traditional AST protocols. : The potential application of LOC for AST of is emphasized by its ability to provide rapid access to minimum inhibitory concentration data, which can substantially aid in selecting the most suitable antibiotics and dosages for treating challenging infections caused by this microorganism. Moreover, the rapid AST facilitated by LOC holds promise for enhancing the appropriateness and efficacy of therapy in clinical settings.
: 是一种普遍存在的细菌,能够引起各种感染,包括皮肤和软组织感染、血流感染、肺炎和手术部位感染。 在全球医疗保健环境中, 尤其是耐甲氧西林 的出现引发了人们对 抗生素耐药性 的极大关注。 在开具抗生素之前,理想的方法是进行抗生素药敏试验(AST); 然而,这通常被认为过于复杂和耗时。 微流控芯片(LOC)技术有望解决这些挑战,推进基础微生物学研究,同时为治疗策略的发展提供帮助。 本系统评价旨在评估 LOC 在 药敏试验中的潜在应用。
: 本研究遵循 PRISMA 指南。 在审查过程中,使用了各种数据库,包括 SCOPUS、PubMed/MEDLINE、SCIELO 和 LILACS,以及灰色文献来源。
: 本系统评价共纳入了 16 项研究。 所有这些研究都详细描述了 LOC 系统评估 对各种抗生素的敏感性的有效性、快速性和可预测性。 将 LOC 方法与传统的手动方法进行比较,结果表明 LOC 需要的试剂最少。 此外,大多数研究报告称,整个 LOC 过程需要 10 分钟到 7 小时,结果与传统 AST 协议获得的结果同样准确。
: LOC 在 AST 中的潜在应用强调了其提供最低抑菌浓度数据的快速访问能力,这可以极大地帮助选择最适合治疗由这种微生物引起的挑战性感染的抗生素和剂量。 此外,LOC 实现的快速 AST 有望提高临床环境中治疗的适当性和疗效。